Unknown

Dataset Information

In-Vitro Sorbent-Mediated Removal of Edoxaban from Human Plasma and Albumin Solution.


ABSTRACT:

Background and objective

Based on previous experience of sorbent-mediated ticagrelor, dabigatran, and radiocontrast agent removal, we set out in this study to test the effect of two sorbents on the removal of edoxaban, a factor Xa antagonist direct oral anticoagulant.

Methods

We circulated 100 mL of edoxaban solution during six first-pass cycles through 40-mL sorbent columns (containing either CytoSorb in three passes or Porapak Q 50-80 mesh in the remaining three passes) during experiments using human plasma and 4% bovine serum albumin solution as drug vehicles. Drug concentration was measured by liquid chromatography-tandem mass spectrometry.

Results

Edoxaban concentration in two experiments performed with human plasma dropped from 276.8 to 2.7 ng/mL and undetectabl

SUBMITTER: Angheloiu AA 

PROVIDER: S-EPMC7419416 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature